Feedback EADV 2018


International Medical Board & Peer reviewers

Prof. Brigitte Dréno
EADV 2018, Chair, Scientific Programming Committee

Prof. Giuseppe Argenziano
Clinica Dermatologica, Università della Campania L. Vanvitelli, Napoli

Prof. Nicolas Dupin
Service de Dermatologie, Hôpital Cochin AP-HP, Paris, France

Prof. Margarida Gonçalo
Departamento de Dermatologia, Universidade de Coimbra, Portugal

Dr. Victoria Jolliffe
Department of Dermatology, Barts Health NHS Trust, London, UK

Prof. Susana Puig
Servicio de Dermatología, Hospital Clínic de Barcelona, España

Prof. Diamant Thaçi
Exzellenzzentrum Entzündungsmedizin, Universitätsklinikum Schleswig-Holstein, Lübeck, Deutschland


Project Manager
Natalia Lubomirski

Medical Writer
Debbie Anderson, PhD
Langhorne, Pennsylvania, USA

Dr. Victor Desmond Mandel
Dermatology Unit Surgical Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy

Web Designer
Eugénie Munter

Web Developer
Riccardo Raneri

Web Management
Alice Lione

Project Assistant
Robyn Lynch

Production Assistant
Thomas Lione

Marco Cumino

Editorial & Production Director
Giorgio Mantovani

Executive Manager
Rick Lione

Copyright: Infomedica

All rights reserved. Neither this publication nor any part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of Infomedica.
The content published on this website are the Official Highlights from the 27th EADV Congress (Paris, France, 12-16 September 2018).

27th EADV Congress content is made available to an international audience through a licensing agreement between Infomedica and the European Academy of Dermatology and Venereology.

Powered by
Infomedica Medical Education Information

In the course of covering medical congresses, Infomedica, the Publisher, may report on emerging technologies, techniques, and therapies. These reports may discuss drug and device applications that are either not approved by the appropriate regulatory body and/or the national or international Agency (European Medicines Agency, Food and Drug Administration, etc.), are not considered to be within the current standard guidelines for the practice of medicine. The Publisher does not assume any legal liability or responsibility for the accuracy, completeness, or usefulness of the information supplied nor for any opinion expressed in the publication. The Publisher, its agents, and employees will not be liable for any loss or damage arising directly or indirectly from the possession, publication, use of, or reliance on information obtained from the publication. It is provided in good faith without express or implied warranty. Reference to any specific commercial product or service does not imply endorsement or recommendation by the Publisher. In the interest of balance and transparency, no brand names are used in any of the reports or other content of this website. Commercial companies are not permitted any influence on editorial content. Advertisers and sponsors do not see editorial content prior to publication.